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MalaQuickTM versus ParaSight F@ as a diagnostic aid in travellers’ malaria 
Maia Funk, Patricia Schlagenhauf, Alois Tschopp and Robert Steffen University ofzurich Travel Clinic, Institute 
for Social and Preventive Medicine, Sumatrastr. 30, CH-8006 Zzkich, Switzerland 
Abstract 
In this study we assessed whether travellers can perform malaria rapid tests, following the provided 
information leaflet, and correctly interpret performed and pre-prepared test strips. Two Plasmodium 
TM falciparum testing systems, namely MalaQuick (ICT) and ParaSight F@ were used. Test performance 
and test interpretation of pre-prepared tests were compared. There was no significant difference in test 
performance between the 2 tests. Interpretation of prepared test strips in both test systems was very reliable 
in blood parasite densities between 0.1% and 2%, but major problems were encountered at low parasitaemia 
(< 0.1% blood parasites) and also in ParaSight F test strips showing high parasitaemia (> 2% blood 
parasites). Low parasitaemia ParaSight F test strips were correctly interpreted by 52.1% compared with 
10.8% correct interpretations with MalaQuick (P < 0.000 1). Correct interpretation of highly positive 
(> 2% blood parasites) pre-prepared test strips was higher with MalaQuick (96.8%) than with ParaSight F 
(33*8%), I-’ < 0.0001. Both tests were associated with high levels of false-negative interpretations which 
render them unsuitable as self-diagnostic kits. Efforts must be made to assist lay individuals in test 
performance by technical test improvement, by equiping the test strips with an additional reading aid for 
interpretation, and by providing instruction by a skilled person. 
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Introduction 
Travel to tropical countries shows a continuous annual 
growth and malaria infection is a permanent threat at 
many destinations. Each year some 10 000 travellers 
residing in non-endemic countries are reported to import 
malaria and this figure is considered to be an under- 
estimate (MUENTENER et al., 1999). In travellers, ma- 
laria diagnosis is often made only after return to the home 
countries, and confirmed by trained and skilled labora- 
tory technicians performing a microscope xamination of 
a Giemsa-stained blood smear. The skills and technical 
equipment in developing countries may in some cases be 
suboptimal or unavailable. Malaria, even severe malaria, 
is often not easily distinguishable from other diseases 
(BASSET et al., 1991; LUXEMIWRGER et al., 1998). The 
case-fatality rate of malaria in tourists may rise to over 
3%, even if the diagnosis is made in industrialized 
countries (MUENTENER et al., 1999). Stand-by emer- 
gency treatment for self-administration is often recom- 
mended for certain traveller groups including travellers 
to low-endemicity areas or isolated locations far from 
competent medical services (SCHLAGENHAIJF & STEF- 
FEN, 1994). Self-diagnosis of malaria is difficult under 
such conditions and incorrect treatment of malaria is 
associated with unnecessary adverse events or delayed, 
inappropriate use of the therapy (SCHLAGENHAUF et al., 
1995). It has been suggested that an easily performed, 
reliable malaria diagnostic test kit could be very impor- 
tant for travellers, to support the stand-by treatment 
strategy (SCHLAGENHAUF et al., 1995). 
In 199 1, BARRA et al. demonstrated the presence of 
Plasmodium falciparum histidine-rich protein 2 (PfI-IlW 
2) (HOWARD et al., 1986) in the plasma of humans with 
I? falciparum malaria. The identification of this protein in 
humans with malaria led to the development of non- 
microscopy tests, demonstrating the infection with I? 
falciparum by means of an immunological capture assay. 
The paper test strip has been proven to be sensitive, 
specific and easy to perform and does not require 
eiectricity or equipment. Only a small amount ofun- 
processed blood is needed. The result can be read with 
the naked eve and the components are stable under warm 
conditions -(SHIFF et al., i993). In 1994 BEADLE et al. 
examined the test in a field trial in Kenva. Sensitivitv and 
specificity were good in high-grade carasitaemias; but 
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decreased markedly in lower-grade parasitaemias. The 
value of such tests performed by instructed staff for the 
diagnosis of falciparnm malaria has been shown in 
several studies of commercially available test kits, e.g., 
the ParaSight F@ test (DIETZE et al., 1995; BANCHON- 
GARSORN et al., 1997; FRIAR et aZ., 1997; KODISINGHE 
et al.. 1997: MHARARURWA et al.. 1997: SINGH et al.. 
19978), and ICT Malaria Pf = MalaQ&kTM test (KU: 
MAR, 1996; SINGH et al., 1997b; VALECHA et al., 1998). 
All studies confirmed the usefulness of the rapid detec- 
tion test kits when performed by skilled laboratory 
technicians who are usually experienced in performing 
different immunological tests. These tests detect only l? 
falciparum parasites, which are however responsible for 
> 50% of all imported malaria cases and for the majority 
of life-threatening malaria infections. The value of the 
currently used tests is restricted to areas with predomi- 
nant I? falciparum infection (UGUEN, 1995). In 1996 
TRACHSIER et al. (1999) tested the Becton Dickinson 
Malaria kit, the ParaSight F test, prospectively in 
travellers, but the test did not prove to be suitable for 
travellers’ self-diagnosis of malaria. To evaluate the 
MalaOuick test an additional studv has been uerformed 
with identical methods. The rest&s of these *2 analyses 
are compared in this report. 
Material and Methods 
Subjects 
Healthy travellers aged 20-39 years with destinations 
to areas with low-endemicity for malaria were recruited 
at our travel clinic in Zurich, Switzerland. Older age- 
groups originally recruited had to be excluded from the 
analysis, because of statistically significant differences in 
age, sex or education. 
A group of 93 volunteers performed the MalaQuick 
test between October 1997 and February 1998. This 
group was compared with 7 1 volunteers who performed 
the ParaSight F test in a comparable study in 1996 
(TRACHSIER et al., 1999). The educational level of 
subjects in each study was high with 40.9% at university 
level or equivalent. The 2 study groups were comparable 
with regard to sex and educational status. 
Methods 
The objective of the study was to assess whether a lay 
person can perform and interpret a commercially avail- 
able malaria test following the provided written instruc- 
tions only. 
The study was approved by the University of Zurich 
Ethics Committee. The goal was explained to the 
volunteers before they signed the informed consent form. 
DIAGNOSTIC AIDS IN TRAVELLERS’ MALARIA 
Volunteers were asked to perform a rapid malaria test 
using their own blood according to the provided instruc- 
tion leaflet. They also completed a questionnaire and 
interpreted 5 test strips previously prepared by skilled 
laboratory staff from clinically obtained blood specimens 
with different parasite densities. Study procedures in 
both study populations were identical or adapted for 
different techniques. The pre-prepared test strips, ‘low’ 
(< O.l%), ‘intermediate’ (O.l-2%) and ‘high’ (> 2%) 
parasitaemia, together with ‘negative’ and ‘control’ were 
the same for each traveller in each of the 2 groups and 
they were prepared according to the Giemsa-stained film 
examination of the same blood. They were provided by 
trained laboratory staff at the Swiss Tropical Institute in 
Basel, Switzerland. The ‘control’ test strip was run with 1 
drop of buffer and no control line appeared. Test per- 
formance, questionnaire completion and test interpreta- 
tion of the pre-prepared strips were done immediately at 
the travel clinic. Medical professionals were excluded. 
Materials 
MalaQuick tests (ICT Malaria Pftest) and written test 
instructions (in German) were provided by Standby 
Diagnostics, Munich, Germany. One drop (- 10 uL) 
of whole blood is applied directly on a testcard with a 
paper-like strip imbedded with 2 antibodies specific for 
PMRP-2, one attached to visible colloidal gold and 
impregnated in the sample pad, the other immobilized 
in a line across the strip. If PMRP-2 is present in the 
plasma, it binds to the gold-labelled antibody. It is then 
run with the buffer (reagent A) and will be captured by 
the membrane-attached second antibody, forming a pink 
line. A control line appears above this line confirming the 
validity of the test. Only 10 p,L of blood are required. 
ParaSight F tests and written test instructions (in 
German) were provided by Becton Dickinson, Cockeys- 
ville, MD, USA. The dipstick, a preparation of nitrocel- 
lulose and glass fibre is pretreated with a mouse 
monoclonal antibody (mAb) against PMRP-2 which is 
applied in a line about 1 cm from the base of the dipstick. 
A second dotted line of PfHRP-2 antigen is incorporated 
in the dipstick about 2-3 mm above the line of mAb as a 
reagent control. To perform the test 50 lrL of whole 
blood measured in a capillary glass tube are required. 
The procedure has been previously described in detail 
(TRACHSLER et al., 1999). 
A questionnaire, targeting the assessments, use of the 
diagnostics, interpretation and acceptability of the tests 
was completed by each volunteer. It was designed to 
pinpoint areas of difficulty in the test procedures. 
The data were analysed using SSPS and significance 
was determined using the x2 test with P < 0.05 consid- 
ered to be significant. 
Results 
Performance of self-testing 
The procedure of self-testing showed no significant 
differences between the 2 tests (Fig. 1): 87.1% of the 
MalaQuick subjects and 74.6% of the ParaSight F 
subjects performed the tests correctly. Test performance 
and rating with regards to level of difficulty is shown in 
Figure 2. 
0 
Correct Incorrect No reply 
Fig. 1. PuruSight F’ versus MalaQuickT”: accuracy of test performance. Dark columns, MalaQuick (n = 93); paler columns, 
No problem 
Feasible 
Difficult 
Impossible 
I 
25 50 75 100 
Volunteers’ responses (%) 
Fig. 2. ParaSight F@ versus MalaQuickTM: difficulty rating for test procedures. Dark columns, MalaQuick (n = 93); paler 
PamSight F (n = 71). 
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The MalaQuick test was significantly easier to perform 
(P < 0.0007). No reply to this question was given by 2 
(2.8%) persons in the Par&&t F group. 
Test instructions 
These were considered to be concise and clear by 64 
(68.8%) individuals of the MalaQuick group and by 46 
(64.8%) volunteers in the PamSight F group, but 
identification of test components was a problem for 
many participants. Some 43 (46.2%) of the MalaQuick 
and 33 (46.5%) of PamSight F participants did not 
understand the meaning of specific terms. 
There were significantly (P = 0.003) fewer requests 
for additional test instructions in the MalaQuick group 
compared to the PuruSight F group. Some 65 (69.9%) of 
the MalaQuick and 32 (451%) of the PuruSight F 
subjects considered additional information to be ‘super- 
fluous’. There was no distinct wish in either group to see a 
video demonstration before performing the test. 
Blood collection 
Blood collection was considered to be more difficult 
(P = 0.001) in the PuruSight F group as it was rated as 
‘difficult’ by 48 (67.6%) subjects versus 40 (43%) in the 
MalaQuick group (Fig. 3). 
Test development 
There were no major differences between the groups 
regarding test development. The PuruSight F test pro- 
cedure is more time consuming than that of the Mala- 
Quick test (PC 0.0001). The majority (40, 56.3%) of 
PuruSight F users needed 15-30 mm for the test per- 
formance, whereas almost all (89,95.7%) of MalaQuick 
users did the test in less than 15 min. 
Interpretation of pre-prepured test strips (Table) 
Test interpretation at parasite levels of O* l-2% did not 
differ significantly in the 2 tests. Low parasitaemia of 
< 0.1% parasites was more accurately interpreted with 
PuruSight F (P < 0.0001) whereas high parasitaemia 
showed a higher accuracy (P < 0.000 1) with MalaQuick. 
Pre-prepared ‘negative’ test strips (i.e., no parasitaemia) 
were also better recognized by MalaQuick volunteers 
(P = 0.014). 
User acceptability rating 
There was a high level of acceptance for both tests. 
Only 1 (1.4%) PuruSight F and 0 (0%) MalaQuick users 
felt that such tests were ‘superfluous’. Some 35 (37.6%) 
MalaQuick and 17 (23.9%) PuruSight F volunteers 
considered the tests as ‘indispensable’ for travellers’ 
> 1 finger prick necessary 
Not enough blood collected 
Inhibition to prick the finger 
;o 
Volunteers’ responses (%) 
Fig. 3. ParaSight F@ versus MalaQuick? problems in blood collection. Dark columns, MalaQuick (n = 93); paler columns, 
ParaSight F (n = 71). 
Table. PamSight F@ versus MalaQuickTM: test interpretation of prepared test strips 
Parasite level Positive Negative No result Uncertain No answer 
O-l-2% (positive)” 
ParuSight F 
MalaQuick 
< 0.1% (positive)” 
PuruSight F 
MalaQuick 
0 (negative)” 
ParuSight F 
MalaQuick 
65 (91.5%) 
89 (95.7%) 
(f [y;y; 0 1(1*4%) 
* Oo ; (2.2%) 1 (1.1%) 0 
37 (52.1%) 21 (29.6%) 4 (5.6%) 3 (4.2%) 
10 (10.8%) 67 (72.0%) ; g:;;j 0 14 (15.1%) 0 
0 57 (80.3%) 6 (8.5%) 5 (7.0%) 3 (3.2%) 
3 (3.2) 88 (94.6%) 1 (1.1%) 1 (1.1%) 0 
> 2% (positive)” 
PuruSight F 
MalaQuick 
- (control) 
ParaSight F 
MalaQuick 
24 (33.8%) 19 (26.8%) 15 (21.1%) 10 (14.1%) 3 (3.2%) 
90 (96.8%) 3 (3.2%) 0 0 0 
0 5 (7.0%) 61 (85.9%) 2 (2.8%) 3 (4.2%) 
1 (1.1%) 0 92 (989%) 0 0 
The correct interpretation is given in bold numbers. 
“Expected test results. 
The ‘control’ test strip was run with one drop of buffer, no control line appeared. 
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Acknowledgements needs. The majority of both study populations [53 
(74.6%) of the PuruSight F group and 57 (61.3%) of 
the MalaQuick group] regarded the test as helpful. 
Discussion 
The general difficulties that lay-persons encounter in 
performing laboratory tests are clearly demonstrated in 
this study. The accuracy of test performance was high, 
but not high enough. Some practical difficulties such as 
blood collection or the lack of experience are unavoid- 
able. In an emergency situation, it is doubtful whether 
a febrile, unwell patient could follow the instructions 
and interpret the test correctly even if the need to 
perform the test were great. A drawback with the 
ParuSight F test is the larger amount (50 pL) of blood 
required for successful test performance whereas in the 
MalaQuick test a single droplet (- 10 uL) suffices. 
With both tests the identification of test components 
for lay-persons is a problem and these must be more 
clearly labelled to facilitate identification and handling 
of the components. Efforts have also to be made to 
reduce areas of difficulty such as fingerpricking and to 
increase the ease of the test performance by technical 
means or different optical design. For both tests, it is 
apparent that the test procedures must be modified to 
be practical in daily routine situations for technically 
untrained persons. 
A further problem, which has not been previously 
mentioned, is that the control line indicates that the test 
procedure was correct but not that blood was actually 
tested. Without testing one sinale droo ofblood there will 
be a control line. Theiefore an-additional control should 
be added marking a human blood protein and demon- 
strating that the test has been correctly run with blood 
and buffer. This is particularly important in the Mala- 
Quick procedure, in which no defined quantity of blood 
is tested. 
Test interpretation is an important problem that has 
not been resolved in these tests. Interpretation ofparasite 
densities of O* l-2% is accurate in both test systems. The 
most important limitation of the tests is poor interpreta- 
tion at low (both tests) and high parasitaemia levels 
(PuruSight F). In locations with poor lighting, the results 
may be even worse, especially for elderly people with 
naturally occurring presbyopia or in sick persons with 
possibly impaired vision. Low parasitaemias are most 
common in travellers. False-negative interpretation in 
low parasitaemia of up to 72.0% (MalaQuick) and 
29.6% (PamSight F) is unacceptable. Interpretation of 
high parasitaemia was an additional problem in the 
PuruSight F group, which renders the test unsuitable in 
cases of severe parasitaemia. False-positive interpreta- 
tions were not a major problem, but could lead to the 
inappropriate use of malaria treatment with possible 
concomitant adverse effects or may also lead to delayed 
diagnosis and inappropriate treatment of other impor- 
tant causes of fever such as typhoid or dengue fever. 
Recent literature reports have identified an additional 
problem of possible false-positive test results in the 
presence of rheumatoid factors as shown by GROBIJSCH 
et al. (1999) and BORTOLONI et al. (1998). 
Test interpretation needs additional clarification and 
in-built controls, perhaps by use of reading aids and 
clearer instruction with printed samples of test results 
that can be compared for correct interpretation. This 
could simplify the diagnostic procedure for lay-persons 
and make additional oral instruction superfluous. 
Medical testing systems should be evaluated for lay- 
persons before being sold over the counter and providers 
of such tests should be skilled instructors. The hazard of 
selling a testing system to lay-persons, thus giving a false 
sense of security, must be avoided until such tests are 
fool-proof. The very high user acceptability rate strongly 
suggests that efforts should be made to improve and 
simplify the test performance and interpretation. 
We thank&e volunteers participating in the studies, Standby 
Diagnostics GMBH, Munich, Germanv, and Becton Dickin- 
son;USA, for providing the test kits andMrs Elisabeth Escher 
from the Swiss Tropical Institute in Basel, Switzerland, for the 
pm-prepared test strips for interpretation tests. 
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Growth and maturation of 
Plasmodium falciparum in BacT/Alert 
blood culture system 
K. M. McCarthy, J. Frean, J. Loakes and 
L. D. Liebowitz Department of Clinical Microbiology 
and Infectious Diseases, School of Pathology, University of 
the Witwatersrand and South Afican Institute for Medical 
Research, Johannesburg, Republic of South Africa 
Keywords: blood cultures, BacT/Alert, malaria, diagnosis 
The BacT/Alert microbial detection system (Organon 
Teknika Corporation, Durham, NC) is used intema- 
tionally for culture of bacterial pathogens from blood. 
Aerobic and anaerobic vials contain supplemented tryp- 
tic soy broth with additional complex amino acid and 
carbohydrate substrates in an atmosphere of CO, in air 
(aerobic) or nitrogen (anaerobic) under vacuum. So- 
dium polyanetholesulfonate (0.035%) is used as an 
anticoagulant. Each vial is inoculated with 5- 10 mL of 
blood. If microorganisms are present in the test sample, 
they metabolize the substrate in the culture medium and 
CO2 is produced. The CO2 diffuses through a selectively 
permeable membrane and into a CO* sensor at the base 
of the bottle. Free hydrogen ions generated by the 
interaction of CO2 with HZ0 change the colour of the 
sensor from dark green to yellow. A light-emitting diode 
(LED) projects light on to the sensor. The reflected light 
is measured by a photo detector. As more COZ is gener- 
ated, more light is reflected. This information is trans- 
mitted to a computer. If there has been a sustained 
acceleration in the rate of CO2 production, high initial 
COZ content and/or an unusually high rate of CO2 
production, the sample is determined positive (THORPE 
et al., 1990). 
We report the first 2 cases to our knowledge where the 
growth of Plasmodium falciparum triggered the BacT/ 
Alert microbial detection system and played a role in 
making the diagnosis of malaria in the patients. In 
addition, further investigation using specimens obtained 
from one of the patients showed that the BacT/Alert 
culture medium is able to support the growth and 
maturation of Z? falciparum for at least 72 h. 
Case 1 
A 35year-old man who had arrived from Pakistan via 
Mozambique 1 week earlier presented to the Johannes- 
burg Hospital with a 4-day history of malaise, fever, 
headache, vomiting and jaundice. On examination he 
had a temperature of 39°C a pulse rate of 135/min and a 
blood pressure of 94/60 mmHg. He was confused and 
had terminal neck stiffness but no localizing signs. On 
auscultation his chest was clear and on examination of 
the abdomen no hepatosplenomegaly was noted. A 
generalized tonic-clonic seizure occurred in the ward. 
A working diagnosis of meningitis was made. A compu- 
terized tomography (CT) scan of the brain revealed no 
abnormality. A lumbar puncture was performed. Anae- 
robic and aerobic BacT/Alert culture bottles were each 
inoculated with approximately 10 mL of blood. 
The full blood count taken on admission revealed a 
white cell count of 6.3 X 109/L (normal range 
3.92-9.88 X 109/L), a haemoglobin concentration of 
138 g/dL (normal range 14.3- 188 g/dL) and a platelet 
count of 3 X 109/L (normal range 140400 X 109/L). 
The haematocrit was 0.402 (normal range 0*43-055) 
and the red cell count was 4.43 X 1 O”/L (normal range 
4.89-6.11 X lO”/L). The lumbar puncture was com- 
Table. Results of inoculation of BacT/Alert bottles with blood obtained fkom patients prior to initiation of 
antimalarial therapy 
Thin smear made from bottle contents after 
termination of incubation 
Volume of Inoculum size 
blood (parasitized Duration of 
Patient Bottle Type W-1 cells/L)” incubation (h) Appearance 
2 Ab Aerobic -8 1.24 X lo9 23 Pyknotic, dysmorphic trophozoites 
2 Bb Anaerobic 
-2 
1.24 X lo9 
1:: 
Pyknotic, dysmorphic trophozoites 
1 Cb Aerobic Unknown Multiple infected cells, late 
trophozoites 
1 Db Anaerobic -10 Unknown 12 Crenated red cells, late and 
disintegrated trophozoites 
1 
E 
Anaerobic 5 1.6 X 10” 
z 
Occasional ate trophozoites 
: G 
Aerobic 3 9.3 x 10” Occasional ate trophozoites 
Anaerobic 1 3.1 x 10” 72 Occasional ate trophozoites 
“Calculated on basis of red cell count and % parasitaemia of specimen used to inoculate bottles. 
bOriginal BacT/Alert blood cultures taken on admission. 
